Den Europæiske Union - dansk - EMA (European Medicines Agency)

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotika anvendt i diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris limited - glatirameracetat - injektionsvæske, opløsning i fyldt injektionssprøjte - 20 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris limited - glatirameracetat - injektionsvæske, opløsning i fyldt injektionssprøjte - 40 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

olympus biotech international limited - eptotermin alfa - spondylolistese - narkotika til behandling af knoglesygdomme - opgenra er indiceret til posterolateral lumbal spinal fusion hos voksne patienter med spondylolistese, hvor autograft har mislykkedes eller er kontraindiceret.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - mepivacainhydrochlorid - injektionsvæske, opløsning - 20 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ireland limited - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning - 10 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - bupivacainhydrochlorid monohydrat - injektionsvæske, opløsning - 5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - adrenalintartrat, bupivacainhydrochlorid monohydrat - injektionsvæske, opløsning - 5 mg/ml +5 mikrog/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - bupivacainhydrochlorid monohydrat - injektionsvæske, opløsning - 5 mg/ml